Parras, Alberto
Vílchez-Acosta, Alba http://orcid.org/0000-0001-8268-591X
Desdín-Micó, Gabriela http://orcid.org/0000-0001-8136-4145
Picó, Sara http://orcid.org/0000-0003-3022-8084
Mrabti, Calida
Montenegro-Borbolla, Elena
Maroun, Céline Yacoub
Haghani, Amin http://orcid.org/0000-0002-6052-8793
Brooke, Robert
del Carmen Maza, María
Rechsteiner, Cheyenne http://orcid.org/0000-0003-1527-2319
Battiston, Fabrice http://orcid.org/0009-0001-7036-4526
Branchina, Clémence
Perez, Kevin
Horvath, Steve http://orcid.org/0000-0002-4110-3589
Bertelli, Claire http://orcid.org/0000-0003-0550-8981
Sempoux, Christine
Ocampo, Alejandro http://orcid.org/0000-0002-3731-3647
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
European Molecular Biology Organization (ALTF 444-2021)
Article History
Received: 10 June 2022
Accepted: 9 October 2023
First Online: 27 November 2023
Competing interests
: K.P. and A.O. are co-founders and shareholders of EPITERNA SA (non-financial interests). A.O. is co-founder of Longevity Consultancy Group (non-financial interests). S.H. is a founder of the non-profit Epigenetic Clock Development Foundation which licenses several patents from his former employer UC Regents. These patents list S.H. as inventor. The rest of the authors declare no competing interests.